PRECISION BIOSCIENCES INC Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Precision Biosciences Inc quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Precision Biosciences Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$21.3M, a 72.1% decline year-over-year.
  • Precision Biosciences Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$16.2M, a 17.3% increase year-over-year.
  • Precision Biosciences Inc annual Operating Income (Loss) for 2023 was -$43.7M, a 29.8% increase from 2022.
  • Precision Biosciences Inc annual Operating Income (Loss) for 2022 was -$62.3M, a 58.2% decline from 2021.
  • Precision Biosciences Inc annual Operating Income (Loss) for 2021 was -$39.4M, a 64.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$43.7M +$18.6M +29.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 -$62.3M -$22.9M -58.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 -$39.4M +$70.5M +64.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$110M -$22.6M -25.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$87.2M -$39.3M -82% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
2018 -$47.9M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.